$EHTH
eHealth, Inc.

2023 Q2 Form 10-Q Financial Statement

#000133349323000063 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $66.77M $73.72M
YoY Change 32.45% -29.95%
Cost Of Revenue $253.0K $215.0K
YoY Change -40.19% -269.29%
Gross Profit $66.52M $73.51M
YoY Change 33.07% -30.24%
Gross Profit Margin 99.62% 99.71%
Selling, General & Admin $92.67M $96.40M
YoY Change -1.51% -31.27%
% of Gross Profit 139.32% 131.14%
Research & Development $14.50M $15.54M
YoY Change -18.45% -20.95%
% of Gross Profit 21.8% 21.15%
Depreciation & Amortization $5.151M $5.245M
YoY Change -3.7% 9.77%
% of Gross Profit 7.74% 7.14%
Operating Expenses $14.50M $15.54M
YoY Change -18.45% -20.95%
Operating Profit -$26.15M -$22.89M
YoY Change -42.49% -42.35%
Interest Expense $2.300M $2.580M
YoY Change
% of Operating Profit
Other Income/Expense, Net $108.0K -$592.0K
YoY Change -109.25% -42.02%
Pretax Income -$26.04M -$23.49M
YoY Change -44.16% -42.34%
Income Tax -$2.500M -$3.600M
% Of Pretax Income
Net Earnings -$23.50M -$19.88M
YoY Change -37.33% -39.29%
Net Earnings / Revenue -35.2% -26.96%
Basic Earnings Per Share -$1.18 -$1.01
Diluted Earnings Per Share -$1.18 -$1.01
COMMON SHARES
Basic Shares Outstanding 27.71M shares 27.61M shares
Diluted Shares Outstanding 27.82M shares 27.65M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $189.8M $202.7M
YoY Change -4.72% -12.44%
Cash & Equivalents $153.2M $180.6M
Short-Term Investments $36.62M $22.06M
Other Short-Term Assets $11.08M $11.27M
YoY Change 15.05% -4.73%
Inventory
Prepaid Expenses $1.757M $3.136M
Receivables $643.0K $1.027M
Other Receivables $0.00 $0.00
Total Short-Term Assets $390.2M $420.7M
YoY Change -4.96% -6.42%
LONG-TERM ASSETS
Property, Plant & Equipment $5.034M $4.994M
YoY Change -48.37% -55.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $30.11M $32.40M
YoY Change -17.05% -9.83%
Total Long-Term Assets $663.2M $662.4M
YoY Change -3.09% -7.14%
TOTAL ASSETS
Total Short-Term Assets $390.2M $420.7M
Total Long-Term Assets $663.2M $662.4M
Total Assets $1.053B $1.083B
YoY Change -3.79% -6.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.391M $5.273M
YoY Change 10.34% -35.66%
Accrued Expenses $33.90M $43.26M
YoY Change 27.61% -0.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.75M $51.47M
YoY Change 24.66% -14.77%
LONG-TERM LIABILITIES
Long-Term Debt $66.91M $66.51M
YoY Change 2.3% 2.34%
Other Long-Term Liabilities $4.315M $4.400M
YoY Change -3.16% -3.8%
Total Long-Term Liabilities $71.22M $70.91M
YoY Change 1.95% 1.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.75M $51.47M
Total Long-Term Liabilities $71.22M $70.91M
Total Liabilities $172.5M $183.7M
YoY Change 0.31% -11.32%
SHAREHOLDERS EQUITY
Retained Earnings $12.84M $45.75M
YoY Change -88.14% -70.15%
Common Stock $40.00K $40.00K
YoY Change 0.0% 2.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 12.50M shares
Shareholders Equity $600.9M $627.9M
YoY Change
Total Liabilities & Shareholders Equity $1.053B $1.083B
YoY Change -3.79% -6.86%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$23.50M -$19.88M
YoY Change -37.33% -39.29%
Depreciation, Depletion And Amortization $5.151M $5.245M
YoY Change -3.7% 9.77%
Cash From Operating Activities -$9.428M $60.80M
YoY Change -63.41% 29.06%
INVESTING ACTIVITIES
Capital Expenditures $2.344M $67.00K
YoY Change -153.97% 21.82%
Acquisitions
YoY Change
Other Investing Activities -$14.19M -$22.01M
YoY Change -318.83% -172.44%
Cash From Investing Activities -$16.54M -$24.24M
YoY Change -871.68% -192.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.248M -$439.0K
YoY Change -36.16% -100.67%
NET CHANGE
Cash From Operating Activities -9.428M $60.80M
Cash From Investing Activities -16.54M -$24.24M
Cash From Financing Activities -1.248M -$439.0K
Net Change In Cash -27.21M $36.23M
YoY Change 6.39% -73.87%
FREE CASH FLOW
Cash From Operating Activities -$9.428M $60.80M
Capital Expenditures $2.344M $67.00K
Free Cash Flow -$11.77M $60.74M
YoY Change -45.05% 29.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001333493
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-33071
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
EHEALTH, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2357876
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2625 AUGUSTINE DRIVE, SUITE 150
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
SANTA CLARA
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054
CY2023Q1 dei City Area Code
CityAreaCode
650
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
210-3150
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
EHTH
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27709543 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180633000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
144401000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
22059000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1027000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2633000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
205679000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
242749000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11266000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11301000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
420664000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
401084000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
596354000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
641555000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4994000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5501000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25381000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26516000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3239000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3239000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32402000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34716000 usd
CY2023Q1 us-gaap Assets
Assets
1083034000 usd
CY2022Q4 us-gaap Assets
Assets
1112611000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5273000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6732000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
27884000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20690000 usd
CY2023Q1 ehth Accrued Marketing Expenses
AccruedMarketingExpenses
8751000 usd
CY2022Q4 ehth Accrued Marketing Expenses
AccruedMarketingExpenses
23770000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6628000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6486000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2931000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2887000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
51467000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60565000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
66508000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
66129000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28748000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32359000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32549000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34187000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4400000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5132000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
183672000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
198372000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
271454000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
263284000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
40000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
40000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
782065000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
777187000 usd
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
199998000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
199998000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
45751000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
73799000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
50000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-73000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
627908000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
650955000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1083034000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1112611000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73723000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105250000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
215000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
-127000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
32899000 usd
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
58454000 usd
CY2023Q1 ehth Customer Care And Enrollment Expense
CustomerCareAndEnrollmentExpense
26957000 usd
CY2022Q1 ehth Customer Care And Enrollment Expense
CustomerCareAndEnrollmentExpense
42164000 usd
CY2023Q1 ehth Technology And Content Expense
TechnologyAndContentExpense
15544000 usd
CY2022Q1 ehth Technology And Content Expense
TechnologyAndContentExpense
19663000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21002000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19987000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
4823000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
96617000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
144964000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22894000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-39714000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-592000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1021000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23486000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40735000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3608000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7993000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-19878000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-32742000 usd
CY2023Q1 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
5101000 usd
CY2022Q1 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
4717000 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3069000 usd
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2501000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28048000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39960000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.46
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.46
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27648000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27648000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27278000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27278000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-19878000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-32742000 usd
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
13000 usd
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
8000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
110000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
23000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19755000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32711000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
650955000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
428000 usd
CY2023Q1 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
8170000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5306000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
123000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-19878000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
627908000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
749519000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1054000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
508000 usd
CY2022Q1 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
7218000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5791000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
31000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-32742000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
715927000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-19878000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-32742000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
656000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
946000 usd
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
4589000 usd
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
3832000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4994000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5285000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3611000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8032000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-61000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-215000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1605000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3773000 usd
CY2023Q1 ehth Increase Decrease In Commissions Receivable
IncreaseDecreaseInCommissionsReceivable
82507000 usd
CY2022Q1 ehth Increase Decrease In Commissions Receivable
IncreaseDecreaseInCommissionsReceivable
77142000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
125000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-12418000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1493000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5525000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7193000 usd
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2042000 usd
CY2023Q1 ehth Increase Decrease In Accrued Marketing Expenses
IncreaseDecreaseInAccruedMarketingExpenses
-15019000 usd
CY2022Q1 ehth Increase Decrease In Accrued Marketing Expenses
IncreaseDecreaseInAccruedMarketingExpenses
-16848000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-372000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-223000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-304000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4829000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
60803000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47112000 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2164000 usd
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4205000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
22009000 usd
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3938000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
34319000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24240000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26121000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
64862000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1054000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
-428000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
-508000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
11000 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
35000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-439000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65373000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36232000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
138637000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147640000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85165000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183872000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
223802000 usd
CY2023Q1 ehth Number Of Health Insurance Carriers
NumberOfHealthInsuranceCarriers
200 insurance_carrier
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
50 state
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11266000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
Significant Accounting Policies, Estimates and Judgments – The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the fair value of investments, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates.
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73723000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105250000 usd
CY2021Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2250000 shares
CY2023Q1 us-gaap Cash
Cash
24390000 usd
CY2022Q4 us-gaap Cash
Cash
17776000 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
156243000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
126625000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180633000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
144401000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3239000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3239000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183872000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147640000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3200000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3200000 usd
CY2023Q1 us-gaap Contract With Customer Asset Allowance For Credit Loss Writeoff
ContractWithCustomerAssetAllowanceForCreditLossWriteoff
0 usd
CY2022 us-gaap Contract With Customer Asset Allowance For Credit Loss Writeoff
ContractWithCustomerAssetAllowanceForCreditLossWriteoff
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
2398000 usd
CY2021Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
2198000 usd
CY2023Q1 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
236000 usd
CY2022 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
-200000 usd
CY2023Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
2162000 usd
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
2398000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
884304000 usd
CY2023Q1 us-gaap Proceeds From Commissions Received
ProceedsFromCommissionsReceived
150510000 usd
CY2023Q1 us-gaap Contract With Customer Asset Allowance For Credit Loss Period Increase Decrease
ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
236000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
802033000 usd
CY2023Q1 ehth Prepaid Maintenance Contracts Current
PrepaidMaintenanceContractsCurrent
5526000 usd
CY2022Q4 ehth Prepaid Maintenance Contracts Current
PrepaidMaintenanceContractsCurrent
5211000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3136000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2858000 usd
CY2023Q1 ehth Prepaid Licenses
PrepaidLicenses
1196000 usd
CY2022Q4 ehth Prepaid Licenses
PrepaidLicenses
1116000 usd
CY2023Q1 us-gaap Prepaid Insurance
PrepaidInsurance
1137000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1893000 usd
CY2023Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
271000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
223000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11301000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
178326000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
178302000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
126664000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
126625000 usd
CY2023Q1 ehth Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost
CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost
178326000 usd
CY2023Q1 ehth Cash Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
10000 usd
CY2023Q1 ehth Cash Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
34000 usd
CY2023Q1 ehth Cash Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsAndAvailableForSaleDebtSecurities
178302000 usd
CY2022Q4 ehth Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost
CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost
126664000 usd
CY2022Q4 ehth Cash Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q4 ehth Cash Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
39000 usd
CY2022Q4 ehth Cash Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsAndAvailableForSaleDebtSecurities
126625000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
28 security
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
26 security
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
400000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
500000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1500000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1600000 shares
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
12500000 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
12100000 shares
CY2023Q1 ehth Treasury Stock Shares Outstanding Shares Acquired Previously Cancelled Vested Shares Withheld For Tax Purposes
TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes
1800000 shares
CY2022Q1 ehth Treasury Stock Shares Outstanding Shares Acquired Previously Cancelled Vested Shares Withheld For Tax Purposes
TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes
1400000 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5791000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4994000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5285000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1170000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1225000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4994000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5285000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
312000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
506000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5306000 usd
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 ehth Sale Of Stock Consideration Received On Transaction Gross
SaleOfStockConsiderationReceivedOnTransactionGross
225000000 usd
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
214000000 usd
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
11000000 usd
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2021Q2 ehth Preferred Stock Convertible Stated Value
PreferredStockConvertibleStatedValue
100
CY2023Q1 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
79.5861
CY2021Q2 ehth Convertible Preferred Stock Votes
ConvertiblePreferredStockVotes
1 vote
CY2021Q1 ehth Convertible Preferred Stock Covenant Asset Coverage Ratio
ConvertiblePreferredStockCovenantAssetCoverageRatio
2
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
11000000 usd
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
214000000 usd
CY2023Q1 ehth Convertible Preferred Stock Redemption Put Right Percentage Of Accrued Value
ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValue
1.35
CY2023Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
0 shares
CY2023Q1 ehth Convertible Preferred Stock Accrued Paid In Kind Dividends Common Stock Equivalent As Converted Basis
ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis
3300000 shares
CY2021Q2 ehth Sale Of Stock Consideration Received On Transaction Gross
SaleOfStockConsiderationReceivedOnTransactionGross
225000000 usd
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
10975000 usd
CY2021Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
214025000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
232592000 usd
CY2022 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
19357000 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
11335000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
263284000 usd
CY2023Q1 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
5101000 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3069000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
271454000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28048000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28048000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39960000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-39960000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27648000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27278000 shares
CY2023Q1 ehth Incremental Common Shares Attributable To Options
IncrementalCommonSharesAttributableToOptions
0 shares
CY2022Q1 ehth Incremental Common Shares Attributable To Options
IncrementalCommonSharesAttributableToOptions
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27648000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27278000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.46
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.46
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5395000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4861000 shares
CY2023Q1 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
6578000 usd
CY2023Q1 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
2770000 usd
CY2023Q1 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
229000 usd
CY2023Q1 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
0 usd
CY2023Q1 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
0 usd
CY2023Q1 ehth Contractual Obligation To Be Paid After Year Four
ContractualObligationToBePaidAfterYearFour
0 usd
CY2023Q1 us-gaap Contractual Obligation
ContractualObligation
9577000 usd
CY2023Q1 ehth Self Insurance Reserve Maximum Benefits Per Employee
SelfInsuranceReserveMaximumBenefitsPerEmployee
300000 usd
CY2023Q1 ehth Self Insurance Reserve Maximum Claim Liability
SelfInsuranceReserveMaximumClaimLiability
13600000 usd
CY2023Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
2000000 usd
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
0 usd
CY2020Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
2 claim
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q1 ehth Allocated Sharebased Compensation Expense Net Of Restructuring Reversal Expense
AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
4994000 usd
CY2022Q1 ehth Allocated Sharebased Compensation Expense Net Of Restructuring Reversal Expense
AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
5285000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5245000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4778000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
4823000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-592000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1021000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23486000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40735000 usd
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
35475000 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
38296000 usd
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
13500000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2102000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1953000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
2300000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6385000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8404000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8610000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7396000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6773000 usd
CY2023Q1 ehth Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
8201000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
45769000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6592000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
39177000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
1300000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
2100000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
2200000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
2200000 usd
CY2023Q1 ehth Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
2800000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
4823000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
4823000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
366000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
361000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
5000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
339 employee
ehth Restructuring And Related Cost Number Of Positions Eliminated Percentage Of Total Workforce
RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce
0.14
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
4800000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23486000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40735000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3608000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7993000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.154
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3600000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.154
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000000 usd
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196

Files In Submission

Name View Source Status
0001333493-23-000063-index-headers.html Edgar Link pending
0001333493-23-000063-index.html Edgar Link pending
0001333493-23-000063.txt Edgar Link pending
0001333493-23-000063-xbrl.zip Edgar Link pending
a2023q1ex311.htm Edgar Link pending
a2023q1ex312.htm Edgar Link pending
a2023q1ex322.htm Edgar Link pending
a2023q2ex321.htm Edgar Link pending
ehth-20230331.htm Edgar Link pending
ehth-20230331.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
ehth-20230331_cal.xml Edgar Link unprocessable
ehth-20230331_lab.xml Edgar Link unprocessable
ehth-20230331_def.xml Edgar Link unprocessable
ehth-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ehth-20230331_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending